Study to Understand Usage and Effect of Saxagliptin as First Add-On After Metformin in Indian Type 2 Diabetes Mellitus Patients
NCT02588859
·
clinicaltrials.gov ↗
COMPLETED
Status
1200
Enrollment
INDUSTRY
Sponsor class
Conditions
Type 2 Diabetes
Sponsor
AstraZeneca